8

Emotional disorders,and in particular depression, are one of the most pressing problems of modern medicine. According to the World Health Organization, depression affects more than 280 million people worldwide, which determines the high socio-economic importance of this pathology. Modern research has significantly expanded the understanding of the neurobiological foundations of emotional disorders, revealing the key role of structural and functional changes in the brain in their pathogenesis

  • Ўқишлар сони 8
  • Нашр санаси 08-03-2025
  • Мақола тилиIngliz
  • Саҳифалар сони123-129
English

Emotional disorders,and in particular depression, are one of the most pressing problems of modern medicine. According to the World Health Organization, depression affects more than 280 million people worldwide, which determines the high socio-economic importance of this pathology. Modern research has significantly expanded the understanding of the neurobiological foundations of emotional disorders, revealing the key role of structural and functional changes in the brain in their pathogenesis

№ Ҳавола номи
1 1.AydemirO., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261-265.2.Bessis A., Bechade C., Bernard D., Roumier A. Microglial control of neuronal death and synaptic properties. Glia 2007; 55: 233-238.3.Brody A.L., Saxena S., Mandelken M.A. et al. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry 2001; 50: 171-178.4.Brook O.H., van Hout H.P.J., Stalman W.A.B., de Haan M. Nontricylic antidepressants: predictors of nonadherence. J Clin Psychopharmacol 2006; 26: 643-647.5.Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000; 4: 215-222.6.Colla M., Kronenberg G., Deuschle M. et al. Hippocampal volume reduction and HPA-system activity in major depression. J Psychiat Res 2007; 41: 553-560.7.Davidson R.J. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003; 40: 655-665.8.de Kloet E.R., Derijk R.H., Meijer O.C. Therapy insight: is there an imbalanced response of mineralcorticoid and glucocorticoid receptors in depression? Nat Clin Pract Endocrinol Metab 2007; 3:168-179.9.Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition, Text-Revision. Washington, DC: American Psychiatric Press 2000.10.Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu Rev Med 1998; 49: 341-361.11.Duman R.S. Neurotrophic factors and regulation of mood: role of exercise, diet, and metabolism. Neurobiol Aging 2005; 6: Suppl: 88-93.12.Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54: 597-606.13.Duman R.S., Monteggia L.M. A neurotrophic model for stress related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.14.Duric V., McCarson K.E. Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience 2005; 6: 999-1006.15.Fava M., Mallinckrodt C.H., Detke M.J. et al. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates. J Clin Psychiatry 2004; 65: 521-530.16.Frank M.G., Baratta M.V., Sprunger D.B., Watkins L.R., Maier S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007; 21: 47-59.
Кутилмоқда